Fundraising September 15, 2024 – October 1, 2024 About fundraising

Volume 23; Issue 31

Main
Vaccine
Volume 23; Issue 31

Vaccine

Volume 23; Issue 31

1

Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice

Qiong Yang, Li Wang, Da-ning Lu, Rui-juan Gao, Jin-na Song, Pan-yu Hua, Da-wei Yuan

Journal:

Year:

2005

Language:

english

File:

PDF, 265 KB

english, 2005

2

Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8–10-year-old children

Bernard Duval, Vladimir Gîlca, Nicole Boulianne, Genevieve Deceuninck, Louis Rochette, Gaston De Serres

Journal:

Year:

2005

Language:

english

File:

PDF, 91 KB

english, 2005

3

The effectiveness of the mumps component of the MMR vaccine: a case control study

Richard Harling, Joanne M. White, Mary E. Ramsay, Karen F. Macsween, Corry van den Bosch

Journal:

Year:

2005

Language:

english

File:

PDF, 143 KB

english, 2005

4

Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains

Mark D. Wareing, Leonard C. Harrison, Gregory A. Tannock

Journal:

Year:

2005

Language:

english

File:

PDF, 110 KB

english, 2005

5

Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs

Aline S. de Aluja, Nelly M. Villalobos, Gabriela Nava, Andrea Toledo, José Juan Martínez, Agustín Plancarte, Luis Felipe Rodarte, Gladis Fragoso, Edda Sciutto

Journal:

Year:

2005

Language:

english

File:

PDF, 239 KB

english, 2005

6

Relative efficacy of inactivated bovine herpesvirus-1 (BHV-1) vaccines

Journal:

Year:

2005

Language:

english

File:

PDF, 426 KB

english, 2005

7

Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P. vivax in Aotus monkeys

Carlos A. Barrero, Gabriela Delgado, Adriana Y. Sierra, Yolanda Silva, Carlos Parra-Lopez, Manuel A. Patarroyo

Journal:

Year:

2005

Language:

english

File:

PDF, 136 KB

english, 2005

8

Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization

Anne-Marte B. Kran, Maja A. Sommerfelt, Birger Sørensen, Jørgen Nyhus, Ingebjørg Baksaas, Johan N. Bruun, Dag Kvale

Journal:

Year:

2005

Language:

english

File:

PDF, 166 KB

english, 2005

9

Alternative codon usage of PRRS virus ORF5 gene increases eucaryotic expression of GP5 glycoprotein and improves immune response in challenged pigs

Ali Kheyar, Ahmed Jabrane, Chengru Zhu, Patrick Cléroux, Bernard Massie, Serge Dea, Carl A. Gagnon

Journal:

Year:

2005

Language:

english

File:

PDF, 235 KB

english, 2005

10

Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge

Marc Busch, Kristina Abel, Jun Li, Michael Piatak Jr., Jeffrey D. Lifson, Christopher J. Miller

Journal:

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

11

A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7(11–20) cytotoxic T lymphocyte epitope

Marco W.J. Schreurs, Esther W.M. Kueter, Kirsten B.J. Scholten, François A. Lemonnier, Chris J.L.M. Meijer, Erik Hooijberg

Journal:

Year:

2005

Language:

english

File:

PDF, 236 KB

english, 2005

12

Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody

J.R. Patel, R.W. Shilleto

Journal:

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

13

Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant

Roberto A. DePaz, Ian Henderson, Siddharth J. Advant

Journal:

Year:

2005

Language:

english

File:

PDF, 252 KB

english, 2005

14

Editorial Board/Aims and Scope

Journal:

Year:

2005

Language:

english

File:

PDF, 56 KB

english, 2005